Beta adrenergic-mediated myofibrillar disruption and enzyme efflux in an experimental myopathy related to isometric muscle activity.
D000313:Adrenal Medulla / Q000503:physiopathology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003402:Creatine Kinase / Q000097:blood*; D007537:Isometric Contraction; D008297:Male; D009135:Muscular Diseases / Q000201:enzymology / Q000473:pathology*; D009210:Myofibrils / Q000187:drug effects* / Q000473:pathology; D010643:Phenoxybenzamine / Q000494:pharmacology; D005082:Physical Exertion; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D000319:Adrenergic beta-Antagonists; D010643:Phenoxybenzamine; D001285:Atropine; D011433:Propranolol; D003402:Creatine Kinase